Pilot study quantifying muscle glycosaminoglycan using bi-exponential T1ρ mapping in patients with muscle stiffness after stroke

Post stroke muscle stiffness is a common problem, which left untreated can lead to disabling muscle contractures. The purpose of this pilot study was to evaluate the feasibility of bi-exponential T-1 rho mapping in patients with arm muscle stiffness after stroke and its ability to measure treatment related changes in muscle glycosaminoglycans (GAGs). Five patients with muscle stiffness after stroke and 5 healthy controls were recruited for imaging of the upper arm with 3D-T-1 rho mapping. Patients were scanned before and after treatment with hyaluronidase injections, whereas the controls were scanned once. Wilcoxon Mann-Whitney tests compared patients vs. controls and patients pre-treatment vs. post-treatment. With bi-exponential modeling, the long component, T-1 rho l was significantly longer in the patients (biceps P=0.01; triceps P=0.004) compared to controls. There was also a significant difference in the signal fractions of the long and short components (biceps P=0.03, triceps P=0.04). The results suggest that muscle stiffness is characterized by increased muscle free water and GAG content. Post-treatment, the T-1 rho parameters shifted toward control values. This pilot study demonstrates the application of bi-exponential T-1 rho mapping as a marker for GAG content in muscle and as a potential treatment monitoring tool for patients with muscle stiffness after stroke.

Automated summary

Post-stroke muscle stiffness is characterized by increased muscle free water and GAG content. Bi-exponential T-1 rho mapping can serve as a marker for GAG content in muscle and a potential treatment monitoring tool for patients with muscle stiffness after stroke, as demonstrated in this pilot study.